Delivery Order SPE2DB22D1017-SPE2DB24FF4BU

Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit organization Cencora, Inc. doing business as AmerisourceBergen. The award is for the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a potential value of $10,560.97 and a completion date of February 16, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The delivery order, valued at $4,471.00, is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp as a single award. This IDC serves as the primary...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of a specialty pharmaceutical product, MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The award, valued at $1,863.54, has an ultimate completion date of April 11, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The award has a potential value of $6,104.00 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is issued under a larger indefinite delivery contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $11,423.09 and a performance period through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $2,104.00, is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The award has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $11,445.72 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a potential value of $1,578.00 and a completion date of March 5, 2024. The delivery order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, to be supplied to DLA Troop Support Medical facilities in Conshohocken, Pennsylvania....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a specialty pharmaceutical product, MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $4,677.42 and a period of performance through April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The award has a ceiling value of $3,832.16 and a completion date of March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF4BU
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award has an ultimate completion date of March 13, 2024 and a ceiling value of $1,282.96.

The delivery order is for the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This award is not associated with any set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The parent company of the prime contractor, AmerisourceBergen Drug Corp, is Cencora, Inc., which does business as AmerisourceBergen.

Generated 6/11/24, 3:54 PM